Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

High levels of testosterone and 5α-DHT can lead to cell death in cells important for hair growth.

Scalp microneedling may improve hair density and thickness for various alopecia types.

Women with low SHBG levels and a high 3a-diol G to SHBG ratio are likely to experience female pattern baldness, possibly due to a slight excess of androgens affecting sensitive hair bulbs.

FAPD is a possible diagnosis for hair loss in patients of color and requires multiple evaluations for accurate diagnosis.

The conclusion is that treatments like finasteride and minoxidil can prevent baldness progression and improve hair density, but more research is needed on other therapies.

Minoxidil can help thicken hair in some people with male pattern baldness, especially if used early and continuously.

Telogen Effluvium is a hair loss condition where treatment involves identifying and managing its triggers.

Reduced alpha smooth muscle actin may cause hair loss in androgenetic alopecia.

New understanding and treatments for hair loss are improving, but more research is needed.

Female hair loss is often hereditary and can be treated with medication, hair transplants, and lasers.

Hair density and thickness decrease in specific scalp areas in people with androgenetic alopecia.

Estrogen replacement can improve skin health in menopausal women but doesn't reverse sun damage or prevent hair loss.

The document concludes that proper diagnosis and FDA-approved treatments for different types of hair loss exist, but treatments for severe cases often fail and future improvements may focus on hair follicle stem cells.

Recent hair loss research shows some progress, especially in understanding male pattern baldness, but effective treatments for many types of hair loss are still lacking.

The document concludes that treatments for cicatricial alopecia are not well-supported by evidence, but hair transplantation shows more predictable and satisfactory results.

Doctors need more training in skin cancer screening, a new treatment is effective for a skin condition, better diagnosis methods for skin cancer are available, hair loss in women may be linked to hormones and cholesterol, certain skin care products might cause hair loss, babies' skin gets weaker after birth, and a gene mutation might be linked to eczema.

Treatments for hair loss include hormone modifiers, minoxidil, and hair transplant surgery.

Alopecia areata is an autoimmune condition causing hair loss, influenced by genetics, stress, and diet, and may be prevented by a high soy oil diet.

Human hair is made up of different keratins, some strong and some weak, with specific types appearing at various stages of hair growth.

Alopecia areata is caused by immune system attacks on hair follicles, often triggered by viral infections.

The document concludes that accurate diagnosis of different types of hair loss requires careful examination of hair and scalp tissue, considering both clinical and microscopic features.

The conclusion is that certain scalp tissue changes are characteristic of lichen planopilaris, with mucinous perifollicular fibroplasia being a new feature for diagnosis.

CCCA is a scarring hair loss condition mainly in African descent women, possibly caused by genetics and hairstyling, treated with gentle hair care and medications.

Trichoscopy is better than trichogram for diagnosing female hair loss.

Beard and scalp hair cells have different gene expressions, which may affect beard growth characteristics.

Minoxidil helps hair regrowth in traction alopecia.

Androgens may block hair growth signals, targeting this could treat hair loss.

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.

Dilated follicular infundibula and increased catagen/telogen follicles are key indicators for diagnosing alopecia areata.

SACUMAN, a rare condition causing hair loss without clear signs, is often misdiagnosed and needs scalp biopsies for accurate detection.